Predict value of ratio of hibernating myocardium in TPD on reverse remodeling and MACEs in HFrEF patients post-revascularization
The International Journal of Cardiovascular Imaging · 2025
DOI: 10.1007/s10554-025-03529-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Cardiovascular Imaging, 2025. Verfasst von Yao Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Laboratory for Molecular Imaging, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Ventricular Remodeling, Ventricular Function, Left, Myocardial Perfusion Imaging, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Beijing Hospitals Authority Clinical Medicine Development of special funding support.
Abstract (Originalsprache)
PURPOSE: This study aimed to assess the predictive value of hibernating myocardium (HM) proportion in total perfusion deficit (TPD) for reverse left ventricular (LV) remodeling and its prognostic significance in heart failure with reduced ejection fraction (HFrEF) patients after revascularization. METHODS: A retrospective analysis of 201 HFrEF patients (178 males, 60.6 ± 9.3 years) who underwent gated myocardial perfusion imaging, 18F-FDG cardiac PET/CT, and echocardiography was performed. Patients were followed for a median of 13.0(7.0) months and received follow-up echocardiography 6 months post-revascularization. Reverse remodeling (RR) was defined as ≥ 10% reduction in LV end-systolic diameter (LVESD). Logistic regression identified predictors of RR, with the predictive value of HM/TPD validated in a prospective cohort (n = 30). Changes were expressed as Δ(post-pre). RESULTS: HM/TPD independently predicted RR (OR = 1.042, 95%CI: 1.019-1.065, P < 0.001). A HM/TPD cutoff of 38.5% demonstrated significant associations with reversed LV remodeling and improved cardiac function post-revascularization, along with a favorable prognosis. The prospective cohort validated these findings. ΔTPD positively correlated with ΔHM (r = 0.825, P < 0.001). CONCLUSIONS: Higher HM/TPD proportion in HFrEF patients was associated with an increased likelihood of RR, improved cardiac function, and favorable outcomes post-revascularization. These findings warrant further prospective investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Laboratory for Molecular Imaging, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- Department of Cardiovascular Surgery Center, Beijing Anzhen Hospital, Beijing, China. dongran6618@hotmail.com.
- Department of Nuclear Medicine, Laboratory for Molecular Imaging, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. xlzhang68@126.com.
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
- Beijing Hospitals Authority Clinical Medicine Development of special funding support
Zitieren
APA
Lu, Y., Wang, Y., Liu, Z., Meng, J., Yun, M., Dong, R., & Zhang, X. (2025). Predict value of ratio of hibernating myocardium in TPD on reverse remodeling and MACEs in HFrEF patients post-revascularization. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-025-03529-0
Vancouver
Lu Y, Wang Y, Liu Z, Meng J, Yun M, Dong R, et al. Predict value of ratio of hibernating myocardium in TPD on reverse remodeling and MACEs in HFrEF patients post-revascularization. The International Journal of Cardiovascular Imaging. 2025. doi:10.1007/s10554-025-03529-0
BibTeX
@article{Lu2025,
author = {Lu, Yao and Wang, Yanlin and Liu, Zihan and Meng, Jingjing and Yun, Mingkai and Dong, Ran and Zhang, Xiaoli},
title = {Predict value of ratio of hibernating myocardium in TPD on reverse remodeling and MACEs in HFrEF patients post-revascularization},
journal = {The International Journal of Cardiovascular Imaging},
year = {2025},
doi = {10.1007/s10554-025-03529-0}
}
EUVIMED